News & Updates
Filter by Specialty:
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.
Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients
18 Oct 2021
Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19
Hospitalized patients with COVID-19 who receive antiplatelet and anticoagulant drugs concurrently may fare better than those given only therapeutic anticoagulation, according to a study.
Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19
18 Oct 2021
Hydroxychloroquine use does not increase risk of heart failure in RA patients
Use of hydroxychloroquine (HCQ) does not contribute to the development of heart failure (HF) in patients with rheumatoid arthritis (RA), a study has shown.
Hydroxychloroquine use does not increase risk of heart failure in RA patients
15 Oct 2021
Methotrexate–leflunomide combo safe in rheumatoid arthritis
Methotrexate (MTX) plus leflunomide (LEF) demonstrates a relatively good safety profile overall compared with the combination of MTX and sulfasalazine (SSZ) and strategies involving advanced therapies in rheumatoid arthritis (RA), reports a study.
Methotrexate–leflunomide combo safe in rheumatoid arthritis
15 Oct 2021
Baricitinib: A potential treatment for alopecia areata?
Baricitinib, an oral, selective Janus kinase (JAK)1/JAK2 inhibitor, may help improve hair growth in patients with severe alopecia areata, according to results from the phase III BRAVE-AA1 and BRAVE-AA2 trials.